Zhang, G., Lu, S., Ren, Z., Wei, L., Chen, C., Tao, P., & Pan, X. (2025). SIRT2 as a Potential Biomarker in Lung Adenocarcinoma: Implications for Immune Infiltration. Molecular Biotechnology, 67(6), 2305. https://doi.org/10.1007/s12033-024-01198-3
Chicago Style (17th ed.) CitationZhang, Guining, Shuyu Lu, Zhiling Ren, Lijuan Wei, Chunxi Chen, Pinyue Tao, and Xiao Pan. "SIRT2 as a Potential Biomarker in Lung Adenocarcinoma: Implications for Immune Infiltration." Molecular Biotechnology 67, no. 6 (2025): 2305. https://doi.org/10.1007/s12033-024-01198-3.
MLA (9th ed.) CitationZhang, Guining, et al. "SIRT2 as a Potential Biomarker in Lung Adenocarcinoma: Implications for Immune Infiltration." Molecular Biotechnology, vol. 67, no. 6, 2025, p. 2305, https://doi.org/10.1007/s12033-024-01198-3.